Clinical Trials Logo

Clinical Trial Summary

Using the spermatic cord block has been of great advantage, as it has been cost saving, efficient technique whether used inon its own or combination with a sedative or . Furthermore, it provides minimal cardiac risks, early case ambulation, satisfactory postoperative pain control, as well as a reduced hospital stay and cost. one of the major drawbacks of spermatic cord block is being a single injection technique, leading to a short postoperative analgesia duration. So, to overcome this flaw some adjuvants were proven to prolong the analgesia duration as Dexmetedomidine (Dex), and magnesium.


Clinical Trial Description

The technique of the spermatic cord block was first described in the 1960s by Earle AS.Using the spermatic cord block has been of great advantage, as it has been cost saving, efficient technique whether used inon its own or combination with a sedative or . Furthermore, it provides minimal cardiac risks, early case ambulation, satisfactory postoperative pain control, as well as a reduced hospital stay and cost. one of the major drawbacks of spermatic cord block is being a single injection technique, leading to a short postoperative analgesia duration. So, to overcome this flaw some adjuvants were proven to prolong the analgesia duration as Dexmetedomidine (Dex), and magnesium. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04498351
Study type Interventional
Source Cairo University
Contact
Status Completed
Phase Early Phase 1
Start date June 30, 2020
Completion date October 22, 2021

See also
  Status Clinical Trial Phase
Completed NCT04492319 - Addition of Neostigmine to Levobupivacaine N/A
Enrolling by invitation NCT06313775 - Comparison of Spinal Anesthesia and Spermatic Cord Block for Bilateral Orchiectomy N/A